What can pharma do to proactively take on climate change?
Casting the net
Related Posts
SynaptixBio awarded £2m BioMedical Catalyst grant from Innovate UK
The grant will support clinical trials of rare disease therapy for leukodystrophy Oxford-based SynaptixBio has […]
Teva and Fosun Pharma partner on early-stage oncology drug
The candidate is being evaluated as both a monotherapy and in combination pembrolizumab Teva Pharmaceutical […]
Professor Bjoern Schelter – PharmaTimes
Frontier Science Scotland appoints Prof Bjoern Schelter as a Director to its Board of Trustees Frontier Science […]